Clinical trials using cord blood in areas of research including autism and cerebral palsy show the potential for it to be a promising option for treatment in the future. Families who have participated in these clinical research trials are thankful to have had the opportunity. But what happens when patients don’t have access to cord blood treatments through clinical trials? That’s where expanded access can help.Read More
What is Hypoplastic Left Heart Syndrome?
Hypoplastic left heart syndrome (HLHS) is a rare, critical birth defect in which the left side of a baby’s heart doesn’t form correctly as it grows during pregnancy. When the left side of the heart is underdeveloped, it restricts normal blood flow to the body and the baby doesn’t get the oxygen within the blood that it needs.Read More
Riding With Confidence – One Boy’s Story About Participating in Recent Phase II Cerebral Palsy and Cord Blood Clinical Trial
After years of searching for an answer, Patrick’s cerebral palsy diagnosis provided the Rooney family with the definitive answer they had been looking for. Read More
Results of a Phase I Clinical Safety Trial using a child’s own cord blood were recently published, and are giving families and researchers hope. Read More
Autism, a disorder that appears in the first three years of life, affects the brain’s development and impacts social and communication skills.1 While the exact causes of Autism Spectrum Disorder (ASD) are unknown, research suggests that both genes and environment play important roles.2 Read More
During November, individuals and organizations across the country are spreading awareness about premature births for Prematurity Awareness Month. As part of honoring Prematurity Awareness Month, we would like to take a minute to thank all of the researchers, medical professionals and organizations around the world that dedicate their time and extraordinary effort to help prevent premature births and improve the lives of premature babies and their families. Read More